Sexual dysfunction: Treat or refer

Obstetrics and Gynecology

Volumn 106, Issue 4, 2005, Pages 834-839

  Sarrel, Philip M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTRADIOL; ESTROGEN; TESTOSTERONE;

ANXIETY; DIAGNOSTIC ACCURACY; HORMONAL THERAPY; HUMAN; MOTIVATION; PATIENT REFERRAL; PHYSICAL EXAMINATION; POSTMENOPAUSE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SEX THERAPY; SEXUAL DYSFUNCTION; SEXUAL FUNCTION;

EID: 25444471609     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000178749.48793.7e     Document Type: Review

References (11)

1. Dennerstein L, Randolph J, Taffe J, Dudley E, Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil Steril 2002;77:S42-8.
2. Sarrel PM, Whitehead MI. Sex and menopause: defining the issues. Maturitas 1985;7:217-24.
3. Masters WH, Johnson VE. Human sexual inadequacy. Boston (MA): Little, Brown & Company; 1970.
4. Basson R. Recent advances in women's sexual function and dysfunction. Menopause 2004;11:714-25.
5. Plaut SM, Graziottin A, Heaton JPW. Sexual dysfunction. Fast facts series. Oxford (UK): Health Press Limited; 2004.
6. Kingsberg S, Althof SE, Leiblum S. Books helpful to patients with sexual and marital problems. J Sex Marital Ther 2002;28(3):219-28.
7. Rioux JE, Devlin MC, Gelfand MM, Steinberg WM, Hepburn DS. 17 beta-E2 vaginal tablets versus conjugated equine estrogen cream to relieve menopausal atrophic vaginitis. Menopause 2000;7:156-61.
8. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-44.
9. Davis SR, McCloud P, Strauss BJ, Burger H. Testosterone enhances E2's effects on postmenopausal bone density and sexuality. Maturitas 1995;21:227-36.
10. Buster JE, Kingsberg SA, Aguirre O, Brown C, Breaux JG, Buch A, et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 2005;105:944-52.
11. Hormone therapy: summary of balancing risks and benefits. ACOG Task Force for Hormone Therapy. American College of Obstetricians and Gynecologists Women's Health Care Physicians. Obstet Gynecol 2004;104 suppl: S5-S129.